Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

The Coming Age of Flavonoids in the Treatment of Diabetic Complications.

Caro-Ordieres T, Marín-Royo G, Opazo-Ríos L, Jiménez-Castilla L, Moreno JA, Gómez-Guerrero C, Egido J.

J Clin Med. 2020 Jan 27;9(2). pii: E346. doi: 10.3390/jcm9020346. Review.

2.

Nrf2 Activation Provides Atheroprotection in Diabetic Mice Through Concerted Upregulation of Antioxidant, Anti-inflammatory, and Autophagy Mechanisms.

Lazaro I, Lopez-Sanz L, Bernal S, Oguiza A, Recio C, Melgar A, Jimenez-Castilla L, Egido J, Madrigal-Matute J, Gomez-Guerrero C.

Front Pharmacol. 2018 Jul 31;9:819. doi: 10.3389/fphar.2018.00819. eCollection 2018.

3.

SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition.

Lopez-Sanz L, Bernal S, Recio C, Lazaro I, Oguiza A, Melgar A, Jimenez-Castilla L, Egido J, Gomez-Guerrero C.

Lab Invest. 2018 Oct;98(10):1276-1290. doi: 10.1038/s41374-018-0043-6. Epub 2018 Mar 14.

Supplemental Content

Loading ...
Support Center